Back to Search
Start Over
[Preeclampsia: Should screening and pronostic biomarkers be used in common clinical practice?]
- Source :
-
Presse medicale (Paris, France : 1983) [Presse Med] 2019 Oct; Vol. 48 (10), pp. 1032-1036. Date of Electronic Publication: 2019 Oct 30. - Publication Year :
- 2019
- Subjects :
- Angiogenic Proteins antagonists & inhibitors
Angiogenic Proteins metabolism
Anti-Inflammatory Agents, Non-Steroidal therapeutic use
Aspirin therapeutic use
Biomarkers metabolism
Female
Humans
Pre-Eclampsia etiology
Pre-Eclampsia physiopathology
Pregnancy
Pregnancy Trimester, First
Pregnancy Trimester, Second
Pregnancy Trimester, Third
Prevalence
Prognosis
Vascular Endothelial Growth Factor A blood
Vascular Endothelial Growth Factor A metabolism
Biomarkers blood
Pre-Eclampsia blood
Pre-Eclampsia diagnosis
Subjects
Details
- Language :
- French
- ISSN :
- 2213-0276
- Volume :
- 48
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Presse medicale (Paris, France : 1983)
- Publication Type :
- Academic Journal
- Accession number :
- 31676218
- Full Text :
- https://doi.org/10.1016/j.lpm.2019.09.029